Definitive Healthcare Corp (DH)
NASDAQ:DH
Want to see DH full AI Analyst Report?
DH Stock Chart & Stats
$1.03
-$0.06(-1.41%)
At close: 4:00 PM EST
$1.03
-$0.06(-1.41%)
Day’s Range― - ―
52-Week Range$0.80 - $4.70
Previous CloseN/A
Volume69.97K
Average Volume (3M)338.90K
Market Cap
$120.68M
Enterprise Value$110.41M
Total Cash (Recent Filing)$178.09M
Total Debt (Recent Filing)$169.84M
Price to Earnings (P/E)―
Beta1.58
Next Earnings
Aug 12, 2026EPS Estimate
0.04Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.62
Shares Outstanding105,524,240
10 Day Avg. Volume311,870
30 Day Avg. Volume338,897
Financial Highlights & Ratios
PEG Ratio0.03
Price to Book (P/B)1.09
Price to Sales (P/S)1.27
P/FCF Ratio8.26
Enterprise Value/Market Cap0.91
Enterprise Value/Revenue0.46
Enterprise Value/Gross Profit0.64
Enterprise Value/Ebitda9.52
Forecast
1Y Price Target
$2.15Price Target Upside108.74% Upside
Rating ConsensusHold
Number of Analyst Covering7
EPS Forecast (FY)0.18
Revenue Forecast (FY)$223.50M
Bulls Say, Bears Say
Bulls Say
Recurring Subscription Model & Services ExpansionDefinitive’s core SaaS subscription model, complemented by 25% YoY professional services growth, diversifies revenue and boosts customer expansion. Durable recurring licenses plus rising services revenue improve customer onboarding, deepen stickiness, and provide higher-margin upsell pathways over multiple quarters.
High And Improving Gross And EBITDA MarginsSustained ~80%+ gross margins indicate strong unit economics for data products. Recent ~260bp EBITDA margin expansion shows operating leverage and cost discipline, enabling durable profitability improvements if revenue stabilizes and fixed-cost absorption continues across the subscription base.
Positive Free Cash Flow And Conservative LeverageConsistent positive operating and free cash flow provides flexibility to invest in product, integrations, and AI roadmaps while avoiding material new leverage. Conservative capital structure reduces refinancing risk and supports multi-quarter execution even amid near-term revenue pressure.
Bears Say
Contracting Revenue And Top-line DeclinesSustained revenue contraction undermines scale economics and complicates converting high gross margins into net profitability. Multi-quarter top-line declines shrink addressable monetization per customer and make long-term margin and cash targets dependent on successful product-led growth and retention improvements.
Shift To Shorter-duration Deals Reducing VisibilityA structural shift toward single‑year contracts lowers revenue visibility and average customer lifetime value, increasing churn and renewal risk. Shorter commitments weaken forward bookings and complicate long-term planning, pressuring investment returns and making growth more reliant on continuous new sales.
Persistent GAAP Losses And Weak ReturnsOngoing GAAP losses have generated deeply negative returns historically, which can erode equity and limit reinvestment if sustained. Even with strong gross margins, continued operating losses pressure balance sheet resilience and raise execution demands to translate margins into consistent net profitability.
Definitive Healthcare Corp News
DH FAQ
What was Definitive Healthcare Corp’s price range in the past 12 months?
Definitive Healthcare Corp lowest stock price was $0.80 and its highest was $4.70 in the past 12 months.
What is Definitive Healthcare Corp’s market cap?
Definitive Healthcare Corp’s market cap is $120.68M.
When is Definitive Healthcare Corp’s upcoming earnings report date?
Definitive Healthcare Corp’s upcoming earnings report date is Aug 12, 2026 which is in 59 days.
How were Definitive Healthcare Corp’s earnings last quarter?
Definitive Healthcare Corp released its earnings results on May 07, 2026. The company reported $0.06 earnings per share for the quarter, beating the consensus estimate of $0.033 by $0.027.
Is Definitive Healthcare Corp overvalued?
According to Wall Street analysts Definitive Healthcare Corp’s price is currently Undervalued.
Does Definitive Healthcare Corp pay dividends?
Definitive Healthcare Corp does not currently pay dividends.
What is Definitive Healthcare Corp’s EPS estimate?
Definitive Healthcare Corp’s EPS estimate is 0.04.
How many shares outstanding does Definitive Healthcare Corp have?
Definitive Healthcare Corp has 105,524,240 shares outstanding.
What happened to Definitive Healthcare Corp’s price movement after its last earnings report?
Definitive Healthcare Corp reported an EPS of $0.06 in its last earnings report, beating expectations of $0.033. Following the earnings report the stock price went up 3.254%.
Which hedge fund is a major shareholder of Definitive Healthcare Corp?
Currently, no hedge funds are holding shares in DH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Definitive Healthcare Corp Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$2.15 (108.74% Upside)
$2.15 (108.74% Upside)
Hedge Fund Trend
Decreased
By 85.7K Shares
Last Quarter.
Last Quarter.
Technicals
SMA
Negative
20 days / 200 days
Momentum
-35.79%
12-Months-Change
Fundamentals
Return on Equity
-67.07%
Trailing 12-Months
Asset Growth
-36.35%
Trailing 12-Months
Company Description
Definitive Healthcare Corp
Definitive Healthcare Corp. (DH), operating through its various subsidiaries, offers specialized commercial intelligence solutions for the U.S. healthcare industry. The company's services furnish essential data on healthcare providers and their activities, enabling clients to navigate critical business processes, from the early stages of product development to strategic market entry planning and effective sales and marketing execution. Its sophisticated platform incorporates sixteen distinct intelligence modules. These modules are designed to support key functional domains such as sales optimization, marketing initiatives, clinical research, new product creation, strategic planning, human capital acquisition, and the oversight of physician networks. Definitive Healthcare caters to a broad spectrum of clients, including biopharmaceutical firms, medical device manufacturers, healthcare information technology companies, and direct healthcare providers. Additionally, its clientele extends to diverse organizations within the wider healthcare ecosystem, such as staffing and commercial real estate companies, financial institutions, and other related entities. Founded in 2011, Definitive Healthcare Corp. is headquartered in Framingham, Massachusetts.
DH Company Deck
DH Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call presents a mixed but constructive picture: near-term top-line pressures persist, driven by the life sciences segment and a shift to shorter-duration deals (reflected in declines in revenue, deferred revenue, and RPO). Offsetting these headwinds are stronger-than-expected profitability and margin expansion, solid cash generation (~$50M trailing FCF), meaningful operational progress on data quality (claims remediation), faster and more numerous integrations, professional services acceleration (+25% YoY), and a clear AI/innovation roadmap that management expects will drive improved retention and future monetization. The company beat guidance on profit metrics and is maintaining full-year targets while investing in strategic initiatives to return to growth, but material execution is still required to translate operational improvements into sustained top-line growth.View all DH earnings summariesDH Stock 12 Month Forecast
Average Price Target
$2.15
▲(108.74% Upside)
Technical Analysis
HealthStream
―
PGIM Securitized Income ETF
―
Evolent Health
―
Phreesia
―
GoodRx Holdings
―
Ownership Overview
12.25% Insiders
4.04% Mutual Funds
61.17% Other Institutional Investors
17.22% Public Companies and
Individual Investors